| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/29/2014 | CN101265260B Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same |
| 01/28/2014 | US8637666 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 01/28/2014 | US8637665 Pyrrolo[2,L-C][L,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof |
| 01/28/2014 | US8637549 Pyridons as PDK1 inhibitors |
| 01/28/2014 | US8637541 Indole derivatives as CRTH2 receptor antagonists |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637531 Pyrido(3,2-d)pyridmidines useful for treating viral infections |
| 01/28/2014 | US8637529 Pyrazolo[3,4-d]pyrimidine compounds |
| 01/28/2014 | US8637527 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
| 01/28/2014 | US8637526 Pyrazolopyrimidine JAK inhibitor compounds and methods |
| 01/28/2014 | US8637516 Compounds and compositions as TRK inhibitors |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637501 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
| 01/28/2014 | CA2738814C Hiv integrase inhibitors |
| 01/28/2014 | CA2608765C Compounds for organic electronic devices |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014014962A1 5ht3 receptor antagonists |
| 01/23/2014 | WO2014014951A1 5-ht3 receptor antagonists |
| 01/23/2014 | WO2014014885A1 Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide |
| 01/23/2014 | WO2014014180A1 Organic compound and organic electroluminescent element comprising same |
| 01/23/2014 | WO2014012614A1 Fused triazole derivatives as gamma secretase modulators |
| 01/23/2014 | WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof |
| 01/23/2014 | US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97 |
| 01/23/2014 | US20140024652 Substituted triazolophthalazine derivatives |
| 01/23/2014 | US20140024634 Indazoles |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/22/2014 | EP2687528A1 Fused triazole derivatives as gamma secretase modulators |
| 01/22/2014 | EP2687508A1 Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by resin transfer molding and having excellent heat resistance |
| 01/22/2014 | EP2686324A1 Piperidine carboxamide spirohydantoin cgrp receptor antagonists |
| 01/22/2014 | EP2686323A1 Macrocyclic compounds as alk, fak and jak2 inhibitors |
| 01/22/2014 | EP2686322A1 Tetraazaperopyrene compounds and their use as n-type semiconductors |
| 01/22/2014 | EP2686321A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/22/2014 | EP2686320A1 Tricyclic gyrase inhibitors |
| 01/22/2014 | EP2686319A1 Imidazo pyrazines |
| 01/22/2014 | EP2686314A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 01/22/2014 | EP2686310A1 Benzodioxane inhibitors of leukotriene production |
| 01/22/2014 | EP2685982A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/22/2014 | EP2685981A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/22/2014 | EP2685826A1 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists |
| 01/22/2014 | EP2037922B1 Prolyl hydroxylase inhibitors |
| 01/22/2014 | CN103534258A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitors |
| 01/22/2014 | CN103534257A Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases |
| 01/22/2014 | CN103534256A Macrocyclic hepatitis c serine protease inhibitors |
| 01/22/2014 | CN103534255A Substituted pyrazolopyrimidines as glucocerebrosidase activators |
| 01/22/2014 | CN103524512A Indole spiro pyrrolo [1,2-c] imidazole compound, and preparation method and application thereof |
| 01/22/2014 | CN103524511A Preparation method of 2,7,12-tribromo-5,10,15-trialkyltricarbazole |
| 01/22/2014 | CN103524510A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/22/2014 | CN103524509A Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 01/22/2014 | CN103524429A Preparation method of ticagrelor and novel intermediates of ticagrelor |
| 01/22/2014 | CN103524420A Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
| 01/22/2014 | CN103520165A Application of indeno triazine compounds as substrate of quinone oxidoreductase depending on NAD (P) H |
| 01/22/2014 | CN102020871B Pigment synergist |
| 01/22/2014 | CN101583614B Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/21/2014 | US8633313 Heterocyclic compounds and their uses |
| 01/21/2014 | US8633212 Inhibitors of beta-secretase |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633206 Pyrrolo[2,3-D]pyrimidine compounds |
| 01/21/2014 | US8633205 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases |
| 01/21/2014 | US8633200 Inhibitors of human immunodeficiency virus replication |
| 01/21/2014 | US8633193 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 01/21/2014 | US8633180 Organic compounds |
| 01/21/2014 | US8632914 Triazolium and imidazolium salts and uses thereof |
| 01/21/2014 | CA2746622C Process for the preparation of cyclopropyl carboxylic acid esters and derivatives |
| 01/21/2014 | CA2691442C Antiviral compounds |
| 01/21/2014 | CA2605050C Histone deacetylase inhibitors |
| 01/16/2014 | WO2014011974A1 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/16/2014 | WO2014011911A2 Irak inhibitors and uses thereof |
| 01/16/2014 | WO2014011840A1 Crystalline forms of an hcv inhibitor |
| 01/16/2014 | WO2014010910A1 Compound, organic electronic element using same, and electronic device thereof |
| 01/16/2014 | WO2014010897A1 Compound, organic electric element using same, and electronic device thereof |
| 01/16/2014 | WO2014010810A1 Novel compound and electroluminescent device including same |
| 01/16/2014 | WO2014009891A1 Heterocyclic compounds for use in the treatment of cancers |
| 01/16/2014 | WO2014009509A1 Macrocyclic purines for the treatment of viral infections |
| 01/16/2014 | WO2014009496A1 Cancer treatment |
| 01/16/2014 | WO2014009447A1 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
| 01/16/2014 | WO2014009317A1 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications |
| 01/16/2014 | WO2014009305A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | WO2014009296A1 Imidazopyrazine derivatives as modulators of tnf activity |
| 01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
| 01/16/2014 | WO2014008673A1 Allopurinol derivative and preparation method and application thereof |
| 01/16/2014 | WO2014008636A1 Macrocyclic compounds as hiv integrase inhibitors |
| 01/16/2014 | WO2012174487A8 Bromodomain inhibitors and uses thereof |
| 01/16/2014 | US20140018374 Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors |
| 01/16/2014 | US20140018361 Irak inhibitors and uses thereof |
| 01/16/2014 | US20140018356 Fused cyclopentyl antagonists of ccr2 |
| 01/16/2014 | US20140018352 Compounds useful as protein kinase inhibitors |
| 01/16/2014 | US20140018351 Pyrazolopyrimidinone Compound and Imidazo Triazone Compound for Treating Erectile Dysfunction |
| 01/16/2014 | US20140018344 Azaindole derivatives |
| 01/16/2014 | US20140018319 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/16/2014 | CA2877543A1 Imidazopyrazine derivatives as modulators of tnf activity |
| 01/16/2014 | CA2876449A1 Aryl sultam derivatives as rorc modulators |
| 01/16/2014 | CA2875057A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/15/2014 | EP2684881A1 Compound having fluorescent chromophore, ion concentration sensor including compound, reagent including compound, reagent kit provided with reagent, precursor of compound, and method for synthesizing compound |
| 01/15/2014 | EP2684880A1 Dispiropyrrolidine derivative |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2683722A1 Fluorophenyl bicyclic heteroaryl compounds |
| 01/15/2014 | EP2683721A1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 01/15/2014 | EP2683720A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES |
| 01/15/2014 | EP2683719A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 01/15/2014 | EP2683717A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate. |